Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.45 |
| ▸ | RELA | Q04206 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.41 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9604202 | 1.00 | MEN1 (0.47) | MEN1KMT2AALDH1A1NPC1MAPT | |
| SCHEMBL515715 | 1.00 | MEN1 (0.47) | MEN1KMT2AALDH1A1NPC1MAPT | |
| SCHEMBL5205967 | 0.86 | ALDH1A1 (0.45) | KMT2AALDH1A1NPC1MAPTSMN1; SMN2 | |
| SCHEMBL5206539 | 0.86 | ALDH1A1 (0.45) | KMT2AALDH1A1NPC1MAPTSMN1; SMN2 | |
| SCHEMBL5201729 | 0.83 | SMN1; SMN2 (0.50) | MEN1KMT2AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL5201537 | 0.83 | MAPT (0.48) | MEN1KMT2AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL5201790 | 0.83 | RXFP1 (0.47) | MEN1KMT2AALDH1A1NPC1MAPT | |
| SCHEMBL5205877 | 0.83 | RXFP1 (0.47) | MEN1KMT2AALDH1A1NPC1MAPT | |
| SCHEMBL5204972 | 0.83 | SMN1; SMN2 (0.50) | MEN1KMT2AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL5201536 | 0.83 | MAPT (0.48) | MEN1KMT2AALDH1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577456-B2 | Light-emitting element, light-emitting device, electronic device, lighting device, and novel organic compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2026-03-17 | — | — | US | disclosed |
| US-20240026217-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20240026217-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20240026217-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| US-11773321-B2 | Light-emitting element, light-emitting device, electronic device, lighting device, and novel organic compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2023-10-03 | — | — | US | disclosed |
| US-11773321-B2 | Light-emitting element, light-emitting device, electronic device, lighting device, and novel organic compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2023-10-03 | — | — | US | disclosed |
| US-11773321-B2 | Light-emitting element, light-emitting device, electronic device, lighting device, and novel organic compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2023-10-03 | — | — | US | disclosed |
| US-20210277305-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-09-09 | — | — | US | disclosed |
| US-20210277305-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-09-09 | — | — | US | disclosed |
| US-11008510-B2 | Light-emitting element, light-emitting device, electronic device, lighting device, and novel organic compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2021-05-18 | — | — | US | disclosed |
| EP-1458706-B1 | DIARYL 1,2,4-TRIAZOLE DERIVATIVES AS A HIGHLY SELECTIVE CYCLOOXYGENASE-2 INHIBITOR | CJ CORP (KR) | 2007-07-11 | — | — | EP | disclosed |
| US-7169929-B2 | Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor | CJ CORP. (KR) | 2007-01-30 | — | — | US | disclosed |
| US-7135572-B2 | Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor | CJ CORP (KR) | 2006-11-14 | — | — | US | disclosed |
| US-20060009495-A1 | Diary 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor | CJ CORP. (KR) | 2006-01-12 | — | — | US | disclosed |
| EP-1611128-A2 | POSITIVE ALLOSTERIC MODULATORS OF THE NICOTINIC ACETYLCHOLINE RECEPTOR | Pharmacia & Upjohn Company LLC (US) | 2006-01-04 | — | — | EP | disclosed |
| EP-1458706-A4 | DIARYL 1,2,4-TRIAZOLE DERIVATIVES AS A HIGHLY SELECTIVE CYCLOOXYGENASE-2 INHIBITOR | CJ CORP (KR) | 2005-06-08 | — | — | EP | disclosed |
| US-20050075373-A1 | Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor | CJ CORP. (KR) | 2005-04-07 | — | — | US | disclosed |
| WO-2004085433-A2 | POSITIVE ALLOSTERIC MODULATORS OF THE NICOTINIC ACETYLCHOLINE RECEPTOR | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-10-07 | — | — | WO | disclosed |
| EP-1458706-A1 | DIARYL 1,2,4-TRIAZOLE DERIVATIVES AS A HIGHLY SELECTIVE CYCLOOXYGENASE-2 INHIBITOR | CJ Corp. (KR) | 2004-09-22 | — | — | EP | disclosed |
| WO-2003055875-A1 | DIARYL 1,2,4-TRIAZOLE DERIVATIVES AS A HIGHLY SELECTIVE CYCLOOXYGENASE-2 INHIBITOR | CJ CORP. (KR) | 2003-07-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060009495-A1 | Diary 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor | PTGS1, PTGS2, PTGES2 | MEN1 4228/4885KMT2A 850/4885ALDH1A1 110/4885 |
| US-20050075373-A1 | Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor | PTGS1, PTGS2, PTGES2 | MEN1 4392/4885KMT2A 1195/4885ALDH1A1 120/4885 |
| US-12577456-B2 | Light-emitting element, light-emitting device, electronic device, lighting device, and novel organic compound | SUN2, LEF1, CTNND1 | MEN1 893/4885KMT2A 2087/4885ALDH1A1 984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.